Trades on 1 secondary market
Inato
Inato is a Paris-based clinical trials technology company (founded 2016) operating an AI-powered marketplace that connects pharmaceutical sponsors, community research sites, and patients to run faster, more inclusive clinical trials. Sponsors post upcoming trials and site needs; the platform uses AI
Inato is an API provider whose private shares are listed on 1 secondary market: EquityZen.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.